Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML
Links shared publicly online about this topic.
- 672total visits
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML
View full resource at medicalnewstoday.com
Tags: Cancer, Leukemia, Chronic Myelogenous Leukemia, Lymphoma, Drug
Most Recently Shared on December 7, 2010 at 3:05 pm By:
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML http://mnt.to/3NFv #clinicaltrials
Also Shared By:
Phase I trial indicates ponatinib may thwart most resistant CML
physorg.com — “A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported at the 52nd Annual Meeting of the American Society ...” View full resource at physorg.com
Most Recently Shared on December 6, 2010 at 5:11 pm By:
Phase I trial indicates ponatinib may thwart most resistant CML http://bit.ly/fXMb28
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML
newswise.com — “A new drug appears to help chronic myeloid leukemia patients who are out of treatment options after first- and second-line drugs have failed them or because their cancer cells have a mutation that makes them resistant from the start, researchers reported at the 52nd Annual Meeting of the American Society of Hematology.” View full resource at newswise.com
Most Recently Shared on December 6, 2010 at 2:20 pm By:
newswise Health Communicator and Health News
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML: A new drug appears to help chronic myeloid leuk... http://bit.ly/eaCAfx
Advertisement
MNT Leukemia
@mnt_leukemia
Phase I Trial Indicates Ponatinib May Thwart Most Resistant CML http://mnt.to/3NFv #lymphoma #leukemia
1 year ago...